Data integrity and digital workflow guidance in a contemporary pharma lab
Join our live webinar on 13 April at 15:00 GMT where we discuss how to achieve data integrity and give real examples from the US Food and Drug Administration (FDA) warning letters about the most frequent and typical violations.
COVID’s impact on cancer therapeutics: clinical trial and treatment disruptions
By Hannah Balfour (European Pharmaceutical Review)
New regulatory landscape for biosimilars in the UK and EU…
By Chris Boyle (Sidley Austin), Marie Manley (Sidley Austin)
The current and future landscape of HIV treatments and vaccines
By Victoria Rees (European Pharmaceutical Review)
Established and new mass spectrometry applications to drug discovery and…
By Dr Ioannis Papayannopoulos